FDA Warns About New Impulse-Control Problems Associated With Abilify
Yesterday, the US Food and Drug Administration (FDA) released a warning that the antipsychotic drug aripiprazole or Abilify is associated with compulsive and uncontrollable...
Antipsychotics Linked to Cognitive & Memory Impairments
Finnish reseachers report in Schizophrenia Research that antipsychotic use is associated with cognitive and memory impairments. The University of Oulu team studied forty people...
Psychotropics During Pregnancy Raise Risk of Babies with Low Birth Weight, Hospitalizations
The use by mothers of any of four major classes of psychiatric medications during pregnancy significantly raises the risk that their babies will be born with low birth weights and will need to be hospitalized.
Olanzapine Can Cause Serious Skin Reaction, FDA Warns
The US FDA has issued a new warning for the atypical antipsychotic Olanzapine, also known by the brand names Zyprexa and Symbyax. The agency...
No Advantage for Second-Generation Antipsychotics
In a study of 720 consecutive hospital admissions in a specific catchment area from 1991 to 2005, researchers found that there was no difference...
Does Longer Duration of Untreated Psychosis Cause Worse Outcomes?
New research counters the long-held assumption that a longer duration of untreated psychosis is associated with worse outcomes.
Nurses Confront the Myths of Psychiatric Drugs
The July issue of Nursing Ethics takes on the myths of psychiatric drugs, saying that "psychiatric drugs are used only to control ‘patient’ behaviour...
Reduction/Discontinuation of Antipsychotics Produces Higher Long-Term Recovery
A study published today in the American Medical Association's journal JAMA Psychiatry reports that patients whose antipsychotic treatment was reduced or discontinued (DR) experienced a recovery...
Randomized Controlled Trial Confirms That Antipsychotics Damage the Brain
A new study published in JAMA Psychiatry connects antipsychotics with damage to the brain in multiple areas.
Antipsychotics Not Helpful for Anorexia
A review of all research on the use of antipsychotics for the treatment of anorexia nervosa found no demonstrable efficacy in terms of body...
Antipsychotics and Drug Addiction
Dopamine supersensitivity as a result of sustained antipsychotic treatment can lead to compulsive drug seeking and drug-taking behavior, according to the theory offered by...
Disconnect Between Antipsychotic Prescribing and Metabolic Screening
Despite American Diabetes Association and APA recommendations of glucose and lipid testing for all patients started on antipsychotics, there is a disconnect between prescribing...
Why Gradual Reduction of Antipsychotics Could Be Safer for Service Users
A new commentary published in Current Opinion in Psychiatry presents the case for slow tapering of antipsychotics. According to authors Mark Horowitz and Joanna...
Less-impaired Youth Using Antipsychotics with Other Medications More Often
Use of second-generation antipsychotics (SGA) alongside other medications is growing rapidly among youth who are less impaired, according to a study published online in...
Better Recovery and Less Relapse Without Meds: A 20-Year Study
Researchers at the University of Illinois College of Medicine found, in a 20-year prospective study of 139 psychotic patients, that patients had a far...
Antipsychotics During Pregnancy Linked to Infant Problems
“Live, healthy babies are the most common outcome following the use of antipsychotic medication in pregnancy,” conclude Australian researchers in a study that was...
Antipsychotic Medications Are Causing Obsessive Compulsive Disorders
Common second-generation antipsychotic medications are causing symptoms of obsessive-compulsive disorder to emerge in many people who previously only had schizophrenia symptoms, according to a...
Majority of Anorexia Patients are Prescribed Psychotropics Despite Lack of Data
Research from the medical schools of Harvard University and the University of Melbourne, reported in the December International Journal of Eating Disorders, found that...
New Review of Antipsychotics for Schizophrenia Questions Evidence for Long Term Use
A systematic review of the limited research available on the long-term effects of antipsychotics finds fewer symptoms in those off of the drugs.
Researchers Call for Reappraisal of Adverse Mental Effects of Antipsychotics, NIDS
In a study published yesterday, researchers from the Nippon Medical School in Tokyo bring attention to a condition known as neuroleptic-induced deficit syndrome (NIDS)...
Anticholinergic Medications Linked to Cognitive Impairment in Schizophrenia
Researchers have found further evidence that the anticholinergic effect of psychiatric drugs can lead to cognitive impairments.
Antipsychotics Associated with White-Matter Reduction
Researchers in China find an acute reduction in white matter in the frontal lobe following six weeks of antipsychotic treatment for "first-episode schizophrenia". Results...
Antipsychotics Lead to Worse Outcomes in First-Episode Psychosis
Those who did not get antipsychotics in the first month were almost twice as likely to be in recovery after five years.
Danish Study Finds Better 10-year Outcomes in Patients Off Antipsychotics
Study finds that 74% of patients with a psychotic disorder off antipsychotics at end of 10 years are in remission.
Antipsychotic Dose Reduction Linked To Long-term Improvements In First-Episode Schizophrenia Patients
Careful reductions in dosage levels of antipsychotic medications over time improved long-term rates of recovery and functional remission in patients diagnosed with a first-episode psychosis.
